Advertisement

Topics

Tessman Technology Limited Company Profile

19:43 EST 14th December 2018 | BioPortfolio

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years later became a wholly owned subsidiary of ILEX Oncology Services, located in San Antonio Texas. There was a managerial buy-out of the company in 2001 with retention of all key managerial and clinical operations staff.

Location

5th Floor Standard Life House, 2 West Regent Street,
Glasgow
Scotland
United Kingdom

Contact

Phone: 44 141 331 9310
Fax: 44 141 331 3793
Email: dtessman@tessmantechnology.com


News Articles [162 Associated News Articles listed on BioPortfolio]

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Quotient Limited Announces Completion of Senior Secured Notes Offering

JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million ...

Quotient Limited Announces Initial MosaiQ™ SDS Verification and Validation Data

JERSEY, Channel Islands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive Verification and Validation...

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously annou...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop,...

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an ...

Veritas Signs MOU with Israeli Cannabis Industry Leader IsCann Group Limited

VANCOUVER, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has...

PubMed Articles [541 Associated PubMed Articles listed on BioPortfolio]

Technology Use Among Youth While Operating Farm Equipment.

Distracted driving by using modern technologies has been linked with increased risk of injuries, however, the current research has focused primarily on the use of technology while operating roadway ve...

New Media, Technology and Neurology Education.

The use of technology in neurology education has revolutionized many aspects of medical teaching, addressing some important challenges of modern education such as information overload and the unique n...

Feasibility Trial of the Newly Introduced Optical Enhancement Technology in Patients with Gastroesophageal Reflux Disease.

Optical Enhancement technology (OE) combines bandwidth-limited light and image enhancement processing technology to enhance subtle mucosal and vascular details. This is the first study assessing the n...

Assistive technology provision: towards an international framework for assuring availability and accessibility of affordable high-quality assistive technology.

This is a position paper describing the elements of an international framework for assistive technology provision that could guide the development of policies, systems and service delivery procedures ...

Real-World Technology Use Among People With Mental Illnesses: Qualitative Study.

There is growing interest in using technology-based tools to support mental health recovery. Yet, despite evidence suggesting widespread access to technology among people with mental illnesses, intere...

Clinical Trials [1480 Associated Clinical Trials listed on BioPortfolio]

User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™

The primary aim of this study is to demonstrate the maintenance of healthy peri-stomal skin over a two month period in subjects who use ConvaTec Moldable Technology™ Skin Barriers as par...

Safety and Efficacy of Using GlucoSat Technology For Non-Invasive Glucose Measurement

This study is a prospective, open label, controlled, single center study. 40 patients will be recruited for the study, according to patients’ inflow and meeting eligibility criteria. Pr...

A Pilot Test of t:Slim X2 With Control-IQ Technology

A 36-48 hour admission testing the t:slim X2 with Control-IQ Technology

Endoleak Repair Guided by Navigation Technology

The study is aimed at investigating whether repair of endoleak type II can be improved by adding navigation technology. Can this technology increase precision by guiding the needle that pu...

Improving Outcomes Using Technology for Children Who Are DHH

This study evaluates the efficacy of using augmentative and alternative communication (AAC) technology for enhancing language development in children who are deaf or hard of hearing. Half ...

Companies [531 Associated Companies listed on BioPortfolio]

Tessman Technology Limited

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years l...

Test-Mall

Tessman Technology is a clinical research organisation focused on the development of investigational agents to treat cancer. The company was established in Edinburgh, Scotland in 1996, and two years l...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Benitec Ltd

Benitec Limited is developing new novel treatments for chronic and life-threatening conditions based on a transformational technology, DNA-directed RNA interference (ddRNAi) - som...

More Information about "Tessman Technology Limited" on BioPortfolio

We have published hundreds of Tessman Technology Limited news stories on BioPortfolio along with dozens of Tessman Technology Limited Clinical Trials and PubMed Articles about Tessman Technology Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tessman Technology Limited Companies in our database. You can also find out about relevant Tessman Technology Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record